Oliver Luxxe Assets LLC Buys New Shares in CVS Health Corporation $CVS

Oliver Luxxe Assets LLC bought a new position in shares of CVS Health Corporation (NYSE:CVS) during the third quarter, HoldingsChannel reports. The firm bought 88,999 shares of the pharmacy operator’s stock, valued at approximately $6,710,000.

Other large investors have also recently added to or reduced their stakes in the company. Avion Wealth grew its holdings in shares of CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. lifted its position in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. Harbor Asset Planning Inc. acquired a new stake in CVS Health during the second quarter worth $30,000. Front Row Advisors LLC increased its holdings in CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 371 shares during the period. Finally, Roxbury Financial LLC raised its stake in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 202 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on CVS shares. Sanford C. Bernstein reissued a “market perform” rating and issued a $91.00 target price on shares of CVS Health in a research note on Tuesday. Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. TD Cowen increased their target price on CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, December 10th. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Truist Financial set a $100.00 price target on CVS Health in a research report on Wednesday, December 10th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $94.86.

CVS Health Stock Down 0.4%

Shares of CVS opened at $80.29 on Friday. The company has a market capitalization of $101.92 billion, a P/E ratio of 211.29, a PEG ratio of 0.74 and a beta of 0.48. CVS Health Corporation has a one year low of $46.34 and a one year high of $85.15. The business’s 50 day simple moving average is $78.70 and its 200-day simple moving average is $73.88. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health’s dividend payout ratio is 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.